Evaluation of aminotransferases, particularly ALT, is also relevant for the assessment of patients with any of a wide array of other hepatic conditions, including metabolic dysfunction−associated steatotic liver disease, autoimmune hepatitis, and hepatitis B infection [27]. Here, GPT is linked to liver disorder.